Fractional CO2 vs. Nonablative 1550 nm: What the Wavelength Actually Decides

Walk into almost any laser practice in Beverly Hills and you will encounter two workhorses of skin resurfacing: the fractional carbon dioxide laser, usually called fractional CO2, and the nonablative fractional 1550 nm erbium-doped fiber laser. Patients often hear them described in marketing shorthand, the "strong one" and the "gentle one." That framing is not wrong, but it skips the part that actually matters: the wavelength determines what the laser does to tissue, and that in turn determines downtime, risk, and what kind of result is realistic.

Start with the target. Both lasers aim at water, the most abundant chromophore in skin. The CO2 laser emits at 10,600 nm, a wavelength water absorbs so efficiently that tissue in the beam path is vaporized. The 1550 nm laser is also absorbed by water, but far less aggressively. Instead of vaporizing tissue, it heats narrow columns of dermis to the point of coagulation while leaving the surface intact. One removes tissue, the other denatures it in place. Everything else flows from that difference.

Ablative means open skin. A fractional CO2 treatment drills microscopic channels through the epidermis into the dermis, removing tissue and leaving a zone of heated collagen around each channel. The skin is physically wounded, which is why patients ooze, crust, and peel for roughly five to ten days depending on density and depth settings. The payoff is that wound healing recruits a robust remodeling response. Fibroblasts deposit new collagen over the following three to six months, and the epidermis regenerates with improved texture. For etched acne scars, deeper static wrinkles, and significant photodamage, ablative fractional resurfacing remains the more powerful single-session tool.

Nonablative means the roof stays on. The 1550 nm device coagulates columns of dermal tissue without breaking the surface. Because the epidermis remains intact, there is no open wound, no crusting, and typically only two to four days of redness and a sandpapery texture as microscopic necrotic debris is shuttled upward and sloughed. The tradeoff is dose. A single nonablative session produces a fraction of the remodeling of a single ablative session, which is why these treatments are sold in series, commonly three to five sessions spaced about a month apart.

The pigment question matters more than the marketing. Beverly Hills practices treat an exceptionally diverse patient population, and this is where wavelength choice becomes a safety decision rather than a preference. Ablative resurfacing carries a meaningful risk of post-inflammatory hyperpigmentation in Fitzpatrick skin types IV through VI, because the inflammatory cascade after an open wound stimulates melanocytes. Nonablative 1550 nm treatment, performed at conservative densities with cooling, has a substantially better safety record in darker skin. It is not zero risk, and pre-treatment with topical agents and strict sun avoidance still matter, but the mechanism explains the gap: less surface injury, less inflammation, less melanocyte activation.

Anesthesia and logistics differ too. Fractional CO2 at clinically meaningful settings usually requires strong topical anesthetic, sometimes nerve blocks or oral medication, and a recovery window during which patients should not wear makeup or exercise heavily. Nonablative sessions typically need only topical numbing and allow makeup within a day or two. For patients who cannot disappear for a week, the math often favors the slower, repeated approach even if the cumulative cost and time are higher.

Myth worth retiring: "nonablative does nothing." Histology studies consistently show new collagen formation after 1550 nm treatment, and stacked sessions produce measurable improvement in fine lines, mild acne scarring, and texture. The honest caveat is expectation calibration. A patient with deep boxcar scars or heavy elastosis who completes four nonablative sessions may achieve perhaps a fraction of what one well-performed fractional CO2 treatment would deliver. The reverse myth, that CO2 is always better, also fails: for early photoaging, melasma-prone skin, or anyone unwilling to accept a week of visible healing, the aggressive option is often the wrong one.

Questions worth asking at a consultation. What density and depth settings does the practice use for someone with your skin type and concern? How do they manage hyperpigmentation risk, including pre-treatment regimens? What is their reasonable estimate of sessions needed, and what does "improvement" mean in percentage terms rather than adjectives? A practice that answers in mechanisms and numbers, rather than before-and-after superlatives, is signaling that it understands the tools.

The bottom line: fractional CO2 and nonablative 1550 nm are not competitors so much as different points on a single tradeoff curve between downtime, risk, and per-session result. The right choice depends on the depth of the problem, the color of the skin, and the realities of your calendar, in roughly that order.